MALIGNANT HYPERTENSION COMPLICATED BY RENAL THROMBOTIC MICRO ANGIOPATHY: ROLE OF ADAM 13 MUTATIONAL ANALYSIS
Abstract
We report a case of a 38-year-old U.A.E national who presented with malignant hypertension and features of thrombotic microangiopathy. He presented with oliguria, renal failure, thrombocytopenia and haemolytic anaemia. He required several sessions of renal replacement therapy. ADAM 13 mutational analysis was sent to differentiate Thrombotic micro angiopathy due to thrombotic thrombocytopenic purpura (TTP) or malignant hypertension. Renal biopsy revealed histopathological features of malignant arteriolar nephrosclerosis (MANS). Haemolytic parameters improved after control of blood pressure and he was subsequently discharged with early nephrology follow up.Keywords: Malignant hypertension; Thrombotic Microangiopathy; MANS; Malignant arteriolar nephrosclerosis; Haemolytic uremic syndrome; HUS; Thrombotic thrombocytopenic purpura; TTPReferences
Higashi AY, Nogaki F, Ono T, Fukatsu A. Case of kidney failure with thrombotic microangiopathy lesions in renal biopsy caused by accelerated hypertension in young adult. Nihon Jinzo Gakkai Shi 2009;51(7):878–83.
Khanna A, McCullough PA. Malignant hypertension presenting as hemolysis, thrombocytopenia, and renal failure. Rev Cardiovasc Med 2003;4(4):255–9.
Bergan JJ, Schmid-Schönbein GW, Smith PD, Nicolaides AN, Boisseau MR, Eklof B. Chronic Venous Disease. N Engl J Med 2006;355(5):488–98.
Zhang B, Xing C, Yu X, Sun B, Zhao X, Qian J. Renal Thrombotic Microangiopathies Induced by Severe Hypertension. Hypertens Res 2008;31(3):479–83.
Feldman JM. Falsely elevated urinary excretion of catecholamines and metanephrines in patients receiving labetalol therapy. J Clin Pharmacol 1987;27(4):288–92.
van den Born BJ, van der Hoeven NV, Groot E, Lenting PJ, Meijers JC, Levi M, et al. Association Between Thrombotic Microangiopathy and Reduced ADAMTS13 Activity in Malignant Hypertension. Hypertension 2008;51(4):862–6.
George JN. How I treat patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Blood 2000;96(4):1223–9.
Shibagaki Y, Fujita T. Thrombotic microangiopathy in malignant hypertension and hemolytic uremic syndrome (HUS)/Thrombotic thrombocytopenic purpura (TTP): Can we differentiate one from the other? Hypertens Res 2005;28(1):89–95.
Remuzzi G. Is ADAM 13 defeciency specific to thrombotic thrombocytopenic purpura? No. J Thromb Haemost 2003;1(4):632–4.
Published
Issue
Section
License
Journal of Ayub Medical College, Abbottabad is an OPEN ACCESS JOURNAL which means that all content is FREELY available without charge to all users whether registered with the journal or not. The work published by J Ayub Med Coll Abbottabad is licensed and distributed under the creative commons License CC BY ND Attribution-NoDerivs. Material printed in this journal is OPEN to access, and are FREE for use in academic and research work with proper citation. J Ayub Med Coll Abbottabad accepts only original material for publication with the understanding that except for abstracts, no part of the data has been published or will be submitted for publication elsewhere before appearing in J Ayub Med Coll Abbottabad. The Editorial Board of J Ayub Med Coll Abbottabad makes every effort to ensure the accuracy and authenticity of material printed in J Ayub Med Coll Abbottabad. However, conclusions and statements expressed are views of the authors and do not reflect the opinion/policy of J Ayub Med Coll Abbottabad or the Editorial Board.
USERS are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author. This is in accordance with the BOAI definition of open access.
AUTHORS retain the rights of free downloading/unlimited e-print of full text and sharing/disseminating the article without any restriction, by any means including twitter, scholarly collaboration networks such as ResearchGate, Academia.eu, and social media sites such as Twitter, LinkedIn, Google Scholar and any other professional or academic networking site.
